Top Stories
Global investment firm Advent to acquire and invest in Sanofi's European generics business, Zentiva, to boost its position in European market.
/ read more /
The transaction is part of Merck KGaA's strategy to actively shape its product portfolio and focus on innovation-driven business.
/ read more /
|
|
|
advertisement
 |
Subscribe
Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.
subscription offers |
 |
|
Industry News
FDA's Center for Drug Evaluation and Research has published its second annual report on key safety programs and activities.
/ read more /
A United States federal judge from the Eastern District of Arkansas entered into a consent decree with Cantrell Drug Company.
/ read more /
More Industry News
|
|
|
|
advertisement
 |
|
Supplier News
The contract renewal allows AMRI to continue to provide medicinal chemistry and ADME services for advancing drug discovery programs in neurotherapeutics.
/ read more /
The new platform is expected to speed up cell line development.
/ read more /
More Supplier News
|
|
|
advertisement
 |
|
Bio/Pharma News
Johnson & Johnson's Janssen partners with Bristol-Myers Squibb to advance next-generation therapies for cardiovascular diseases.
/ read more /
The agency has granted breakthrough therapy designation to Roche's hemophilia therapy for treating hemophilia A in patients without factor VIII inhibitors.
/ read more /
More Bio/Pharma News
|
|
|
advertisement
 |
|
Regulatory News
The agency has released new guidance on the development of new medication-assisted treatments for opioid dependence.
/ read more /
|
|
|
|
|
FORMULATION
The high viscosity of highly concentrated monoclonal antibody formulations not only presents processing and storage difficulties, but also formulation and delivery challenges.
/ read more /
|
|
|
|
MANUFACTURING
Pharma 4.0 envisions highly efficient automated processes, which could be continuous, batch, or a hybrid of these, driven by an integrated manufacturing control strategy.
/ read more /
|
|
|
|
EXCIPIENTS
This article seeks to promote dialogue among stakeholders to facilitate consensus regarding requirements for excipients.
/ read more /
|
|
|
|
Events
May 29–30, 2018
June 4–7, 2018
June 14–15, 2018
more events |
|
|
eBOOKS
 |
Vaccines—from childhood and influenza immunizations, to epidemic prevention, to cancer and therapeutic treatments—present unique development challenges. In this Vaccine and Manufacturing eBook, the editors explore development and manufacturing options to make vaccines more accessible. |
|
|
|
|
|
